Joseph Turgeon has been appointed senior vice president of sales and commercial operations at Spectrum Pharmaceuticals. Mr. Turgeon will be responsible for the commercialization and sales of all Spectrum products, including Fusilev (levoleucovorin) for injection, Foloyn (pralatrexate injection), and Zevalin (ibritumomab tiuxetan) injection for intravenous use. Mr. Turgeon brings over 25 years of pharma sales experience, including various executive leadership roles at Amgen. He will report to Ken...